Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.45 |
| ▸ | PRKCI | P41743 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 3/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | BCL2 | P10415 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | CHKA | P35790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30987236 | 1.00 | TRPA1 (0.52) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL120295 | 0.93 | ALDH1A1 (0.59) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL3357853 | 0.91 | TRPA1 (0.56) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL30987239 | 0.91 | TRPA1 (0.50) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL1311054 | 0.91 | TRPA1 (0.50) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL630242 | 0.89 | TAAR1 (0.45) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL13451385 | 0.89 | CYP4F2 (0.44) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL16675041 | 0.89 | TRPA1 (0.54) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL16675050 | 0.89 | TRPA1 (0.54) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL15125657 | 0.87 | ALDH1A1 (0.50) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085313-A | Polyion liquid-metal organic framework composite material and preparation method and application thereof | 福州大学 | 2024-05-28 | — | — | CN | claimed |
| EP-4692940-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, ELECTRONIC DEVICE, AND ELECTRONIC DEVICE MANUFACTURING METHOD | Sumitomo Bakelite Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024225262-A1 | POLYFUNCTIONAL VINYLBENZYL COMPOUND, RESIN COMPOSITION, PREPREG, RESIN FILM, METAL-CLAD LAMINATED SHEET, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | 株式会社レゾナック | 2024-10-31 | — | — | WO | disclosed |
| US-20240209026-A1 | A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS | PROTAGONIST THERAPEUTICS, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| CN-118085313-A | Polyion liquid-metal organic framework composite material and preparation method and application thereof | 福州大学 | 2024-05-28 | — | — | CN | disclosed |
| US-11840581-B2 | α4β7 thioether peptide dimer antagonists | PROTAGONIST THERAPEUTICS, INC. (US) | 2023-12-12 | — | — | US | disclosed |
| US-20230192767-A1 | IL-2RGAMMA BINDING COMPOUNDS | MCMEEKIN, DERMOT (GB) | 2023-06-22 | — | — | US | disclosed |
| US-20230063321-A1 | Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists | PROTAGONIST THERAPEUTICS, INC. | 2023-03-02 | — | — | US | disclosed |
| US-11548914-B2 | IL-2Rgamma binding compounds | MEDIKINE, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| WO-2022261257-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| EP-0906261-B1 | HYDROFORMYLATION PROCESS AND CATALYSTS SUITABLE THEREFOR CONTAINING PHOSPHORUS COMPOUNDS AS LIGANDS | BASF AG (DE) | 2001-05-09 | — | — | EP | disclosed |
| EP-0906261-A1 | HYDROFORMYLATION PROCESS AND CATALYSTS SUITABLE THEREFOR CONTAINING PHOSPHORUS COMPOUNDS AS LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997046507-A1 | HYDROFORMYLATION PROCESS AND CATALYSTS SUITABLE THEREFOR CONTAINING PHOSPHORUS COMPOUNDS AS LIGANDS | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-11 | — | — | WO | disclosed |
| US-5583131-A | FOR TREATMENT OR PREVENTION OF ACQUIRED IMMUNE DEFICIENCY SYNDROME, REDUCED TOXICITY | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1996-12-10 | — | — | US | disclosed |
| EP-0619813-A1 | LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1994-10-19 | — | — | EP | disclosed |
| WO-1993012096-A1 | LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1993-06-24 | — | — | WO | disclosed |
| US-4564705-A | POLYAMIDE, POLYUREA AND POLYURETHANE MONOMERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-01-14 | — | — | US | disclosed |
| US-4451642-A | Bis(aminoneopentyl) aromatics and polyamides derived therefrom | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4130579-A | Bis(2-methyl-2-cyanopropyl) aromatics | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4107444-A | INTERMEDIATES FOR POLYESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230063321-A1 | Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists | ITGB7, ITGB4, ITGA4 | TRPA1 1146/4885ALDH1A1 2526/4885TSHR 1814/4885 |
| US-11840581-B2 | α4β7 thioether peptide dimer antagonists | EPCAM, SELPLG, VCAM1 | TRPA1 1872/4885ALDH1A1 2562/4885TSHR 575/4885 |
| US-20240209026-A1 | A4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS | EPCAM, ANXA7, GRB7 | TRPA1 1552/4885ALDH1A1 3588/4885TSHR 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.